Neurogene Inc expected to post a loss of $1.14 a share - Earnings Preview

Neurogene

03/05/2024 23:16

* Neurogene Inc  NGNE.OQ   NGNE.O  is expected to show no
change
in quarterly revenue when it reports  results on May 6
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Neurogene Inc is for a
loss of
$1.14 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neurogene
Inc is
$46.00​, above​ its last closing price of $36.63. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -1.17       -1.17      -1.51     Missed  -28.7
  0001                                -1.64             
                                      -0.80             ​
 Mar. 31 2023  -2.51       -2.50      -5.12     Missed  -104.8
 ​​Dec.                    -3.80      -4.80     Missed  -26.3
 31 2022                                                
 Jan. 1 0001   -5.94       -6.09      -4.80     Beat    21.1​
 Jan. 1 0001   -5.95       -6.00      -5.60     Beat    6.7
 Mar. 31 2022  -5.33       -5.93      -5.60     Beat    5.6
 This summary was machine generated May 3 at 22:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)